Which potassium citrate works best for kidney stones? new study aims to find out
NCT ID NCT06819111
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test three different forms of potassium citrate—a medication that helps prevent kidney stones by making urine less acidic. Twenty adults who have had kidney stones will take each form for one week, with a week off in between. Researchers will measure changes in urine acidity and ask participants about side effects and preferences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Potassium citrate (slow-release tablet, powder, and tablet forms)
- What this could lead to
- If successful, this could show which form of potassium citrate works best and is most tolerable for preventing kidney stones.
- What could go wrong
- This is a small, early-phase study with only 20 participants, so results may not apply to everyone. It compares existing drugs, not a new breakthrough.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CALCULI are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the type of anesthesia make surgery easier for the surgeon?
- Can a phosphate binder curb kidney stone risk?
- Can medical glue replace the drainage tube in kidney stone surgery?
- X-ray-free kidney stone surgery put to the test in 500-patient trial
- A shot of bupivacaine at the surgical site may ease pain after kidney stone surgery — a trial puts it to the test
- Can watching and waiting beat surgery for silent kidney stones?